What is the current Price Target for the Aethlon Medical, Inc. stock?

The average Aethlon Medical, Inc. target price is $0.71. This is 84.61% higher than the current stock price. 1 Analyst has issued a Aethlon Medical, Inc. price target 2025.

How high will the Aethlon Medical, Inc. stock rise?

No reliable answer can be given as to how high the Aethlon Medical, Inc. stock will rise. The performance of stocks, including the Aethlon Medical, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Aethlon Medical, Inc. stock today?

The performance of Aethlon Medical, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Aethlon Medical, Inc. stock fall?

The decline in Aethlon Medical, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Aethlon Medical, Inc. Forecast, price target & analysts

$0.39

2.68% today

Nasdaq, Nov 04, 09:12 pm CET

ISIN

US00808Y2081

Symbol

AEMD

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Aethlon Medical, Inc. Target price 2024 - Analyst rating & recommendation

Aethlon Medical, Inc. Classifications & Recommendation:

Hold

100%

Aethlon Medical, Inc. Price Target

Target Price	$0.71
Price	$0.38
Potential	84.61% register free of charge
Number of Estimates	1

	1 Analyst has issued a Aethlon Medical, Inc. price target 2025. The average Aethlon Medical, Inc. target price is $0.71. This is 84.61% register free of charge higher than the current stock price.
	A rating was issued by 1 analysts: 0 Analysts recommend Aethlon Medical, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Aethlon Medical, Inc. stock has an average upside potential 2025 of 84.61% register free of charge . Most analysts recommend the Aethlon Medical, Inc. stock at Hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Mar '24	2025 Estimates
Earnings Per Share $	-4.86	-0.94
	17.06%	80.66%
P/E		negative

1 Analysts have issued a Aethlon Medical, Inc. forecast for earnings per share. The average Aethlon Medical, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-4.86	17.06%
2025	$-0.94 80.66% Unlock
2026	$-0.66 29.79% Unlock

Current	-0.10	62.96%
2025	-0.41 310.00% Unlock
2026	-0.58 41.46% Unlock

Aethlon Medical, Inc....

Discover more stocks with a high price target

Valneva 207.78%

CureVac N.V. 152.80%

Plug Power Inc. 89.59%

Moderna 67.08%

ThyssenKrupp 57.97%

Evotec 47.96%

Bavarian Nordic 47.59%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now